Status:
NOT_YET_RECRUITING
Research on Effects of Drugs on Body Composition and Function With Imaging in Diabetes
Lead Sponsor:
Kristin Clemens
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
One downside of diabetes weight loss drugs like GLP-1RA and GLP-1RA/GIP, is that they can cause muscle loss, which is especially risky for older adults or those already prone to frailty and falls. The...
Detailed Description
In Canada, older adults are projected to represent nearly one-fourth of the population by 2040, with the number of old older adults (75 and older) growing at an even faster rate. This demographic shif...
Eligibility Criteria
Inclusion
- Be at least 18 years old
- Have type 2 diabetes
- Have recently been started on semaglutide or tirzapatide under the care of a physician
- Be able to speak and read English
Exclusion
- Are pregnant or breastfeeding
- Are unable to perform functional tests
- Are unable to provide informed consent
- Have any contraindication to PET/CT scan
- Had a change in body weight over 5 kilograms within 90 days before starting a GLP-1RA or GLP-1RA/GIP
- Had previous or planned (during the study period) bariatric surgery in the subsequent 12 months.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07156331
Start Date
October 1 2025
End Date
December 31 2027
Last Update
September 5 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.